What are the new treatments for advanced lung cancer? Which patients with advanced lung cancer have a better prognosis

Lung cancer, also known as primary bronchial cancer, is the most common primary malignant lung tumor originating from the bronchial mucosa or glands. It can be divided into small cell carcinoma and non-small cell carcinoma. After becoming ill, patients will experience symptoms such as cough, sputum, hemoptysis, and weight loss. Generally, patients with early lung cancer have a high cure rate. When it develops to the late stage, they can only prolong their survival through radiotherapy and chemotherapy. Regarding the relevant issues of lung cancer treatment methods, Zhou Chengzhi, chief physician of the First Affiliated Hospital of Guangzhou Medical University, will explain to us.

What are the new treatments for advanced lung cancer?

New treatments for advanced lung cancer include: 1. Targeted therapy for driver genes. Once the driver gene is found, the corresponding targeted therapy will be very effective; 2. Immunotherapy; 3. Multi-target small molecule anti-vascular drugs. This type of anti-vascular drug can enhance the efficacy and antibodies, and can enhance the efficacy of existing chemotherapy, targeted therapy and immunotherapy. When combined together, they will play a better role in prolonging patient survival.

Which patients with advanced lung cancer will have a better prognosis?

The prognosis of patients with advanced lung cancer will be better depending on the treatment method. According to the current data analysis, the efficacy of driver genes may be better. Immunotherapy has been clinically applied for a relatively short time and the data is not very mature, while targeted therapy has more data and has been applied for a long time. Therefore, at present, people with driver genes who receive targeted therapy have better survival. Moreover, as more and more immunotherapy drugs are available in the future, and more and more combined treatment methods are used, people who receive immunotherapy should also be able to achieve better survival in the future.

Although lung cancer is prone to metastasis, and after metastasis, the impact on the patient's body will be greater, the current clinical treatment technology has a great chance of curing patients. However, the premise of everything is that patients should discover it early and go to the hospital for diagnosis and treatment early. During the treatment, patients should establish a good attitude, actively accept, reasonably treat, take medicine on time, and if adverse reactions occur during medication, they should tell the doctor in time.